APA (7th ed.) Citation

D, M., E, S., JM, O., M, W., A, L., O, P., . . . M, S. (2025). Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease. Molecular psychiatry, 30(7), 3150. https://doi.org/10.1038/s41380-025-03021-0

Chicago Style (17th ed.) Citation

D, Mengel, et al. "Blood Biomarkers Confirm Subjective Cognitive Decline (SCD) as a Distinct Molecular and Clinical Stage Within the NIA-AA Framework of Alzheimer´s Disease." Molecular Psychiatry 30, no. 7 (2025): 3150. https://doi.org/10.1038/s41380-025-03021-0.

MLA (9th ed.) Citation

D, Mengel, et al. "Blood Biomarkers Confirm Subjective Cognitive Decline (SCD) as a Distinct Molecular and Clinical Stage Within the NIA-AA Framework of Alzheimer´s Disease." Molecular Psychiatry, vol. 30, no. 7, 2025, p. 3150, https://doi.org/10.1038/s41380-025-03021-0.